Press Releases
We lead the synthetic biology industry, having developed and successfully commercialized the most Lab-to-Market™ ingredients. Our sustainable ingredients are used in thousands of top global brands, including our own family of consumer brands in Clean Beauty and Health markets.
EMERYVILLE, Calif., May 22, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it plans to participate in a panel discussion entitled, "Closer Examination of Next-Generation Bioproduct Technologies," at Cowen and Company's 43rd Annual Technology, Media & Telecom Conference. The conference will be held May 27-28, 2015, at The New York Palace Hotel in New York City.
John Melo, President & CEO of Amyris, is scheduled to participate on the panel on Thursday, May 28, 2015 at 2:45 p.m. Eastern Time with one-on-one meetings with investors to be held in conjunction with the conference. Due to the format, the panel presentation is not being webcast.
About Amyris
Amyris is the integrated renewable products company that's enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. The company is delivering its No Compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. More information about the company is available at www.amyris.com.
Amyris is a registered trademark of Amyris, Inc.
For media inquiries, please contact: info@amyris.com
For investor inquiries, please contact: investor@amyris.com
